Search - tctmd.com

Displaying 81 - 100 of 178

Sort: Relevancy | Date

Presentation TCT 2013

Motion: PFO Occlusion in a Patient Presenting with Stroke Reduces Recurrence - Against: We Must Accept the Concept of Inappropriate Intervention: PFO Occlusion Should (Almost)...

Presenter: Ted Feldman

October 30, 2013

Presentation TCT 2013

Motion: PFO Occlusion in a Patient Presenting with Stroke Reduces Recurrence - For: The Evidence Base is Clear Enough – All PFOs Should be Closed!

Presenter: Stephan Windecker

October 30, 2013

Presentation TCT 2013

For PFO Closure in Patients with a Long Tunnel

Presenter: John Lasala

October 30, 2013

Presentation TCT 2013

Exploring the Structural Landscape: Reflections on Three Important Closure Therapies (PFO, Mitral Edge-to-Edge, and LAA)

Presenter: Ted Feldman

October 30, 2013

Presentation TCT 2013

Case Presentation Introduction: Patient with a Stroke Found to Have Large PFO

Presenter: Brian Clapp

October 30, 2013

Presentation TCT 2013

Case Presentation Conclusion: Procedural and Patient Outcomes(4)

Presenter: Brian Clapp

October 30, 2013

Presentation TCT 2013

Effect of Intra-cardiac Echocardiography (ICE) and Yearly Operator Volume on Length of Stay and Cost of Care for Percutaneous Closure of Atrial Septal Defects and PFO: A Perspective of Last Decade

Presenter: Nileshkumar J. Patel

October 29, 2013

Presentation TCT 2013

What Went Right and What Went Wrong—and What Should Have Been Done Differently? A Critical Appraisal

Presenter: Robert Sommer

October 27, 2013

Presentation TCT 2013

What Is in the Pipeline for PFO Closure? Devices and Data

Presenter: Horst Sievert

October 27, 2013

Presentation TCT 2013

What Is in the Pipeline for ASD Closure? Devices and Data

Presenter: Zahid Amin

October 27, 2013

Presentation TCT 2013

The Randomized Trial Data

Presenter: Mark Reisman

October 27, 2013

Presentation TCT 2013

The Prospective Registry and New Meta-analysis Data

Presenter: Horst Sievert

October 27, 2013

Presentation TCT 2013

PFO Closure: Regulatory Reform, FDA Approval, and Rational Dispersion in the United States

Presenter: John Carroll

October 27, 2013

Presentation TCT 2013

PFO Closure Would Benefit from a CHADS-Like Score to Select the Patients Who Will Benefit

Presenter: David Thaler

October 27, 2013

Presentation TCT 2013

PFO Closure - Stitched up by Statistical Dogma?

Presenter: David Hildick-Smith

October 27, 2013

Presentation TCT 2013

PFO Case 2

Presenter: Steven Goldberg

October 27, 2013

Presentation TCT 2013

Multidisciplinary PFO Clinic and the Neurology/Cardiology Society Interface

Presenter: David Thaler

October 27, 2013

Presentation TCT 2013

Moving Forward: The Dawn of Patient-Centered Clinical Trials and Translational Tools

Presenter: Bray Patrick-Lake

October 27, 2013

Presentation TCT 2013

Long-term (>10 Years) Outcome of ASD Device Closure

Presenter: John Lasala

October 27, 2013

Presentation TCT 2013

Is ASD Closure a Low Risk Procedure? The Spectrum Complications and Their Management

Presenter: Jonathan Tobis

October 27, 2013

Advertisement

Motion: PFO Occlusion in a Patient Presenting with Stroke Reduces Recurrence - Against: We Must Accept the Concept of Inappropriate Intervention: PFO Occlusion Should (Almost)...

Motion: PFO Occlusion in a Patient Presenting with Stroke Reduces Recurrence - For: The Evidence Base is Clear Enough – All PFOs Should be Closed!

For PFO Closure in Patients with a Long Tunnel

Exploring the Structural Landscape: Reflections on Three Important Closure Therapies (PFO, Mitral Edge-to-Edge, and LAA)

Case Presentation Introduction: Patient with a Stroke Found to Have Large PFO

Case Presentation Conclusion: Procedural and Patient Outcomes(4)

Effect of Intra-cardiac Echocardiography (ICE) and Yearly Operator Volume on Length of Stay and Cost of Care for Percutaneous Closure of Atrial Septal Defects and PFO: A Perspective of Last Decade

What Went Right and What Went Wrong—and What Should Have Been Done Differently? A Critical Appraisal

What Is in the Pipeline for PFO Closure? Devices and Data

What Is in the Pipeline for ASD Closure? Devices and Data

The Randomized Trial Data

The Prospective Registry and New Meta-analysis Data

PFO Closure: Regulatory Reform, FDA Approval, and Rational Dispersion in the United States

PFO Closure Would Benefit from a CHADS-Like Score to Select the Patients Who Will Benefit

PFO Closure - Stitched up by Statistical Dogma?

PFO Case 2

Multidisciplinary PFO Clinic and the Neurology/Cardiology Society Interface

Moving Forward: The Dawn of Patient-Centered Clinical Trials and Translational Tools

Long-term (>10 Years) Outcome of ASD Device Closure

Is ASD Closure a Low Risk Procedure? The Spectrum Complications and Their Management

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content